2020 American Transplant Congress » Late Breaking Oral Abstract

3:15pm-3:27pm

The Centers for Medicare and Medicaid Services’ Proposed Metrics for Recertification of Organ Procurement Organizations: Evaluation by the Scientific Registry of Transplant Recipients

J. Snyder¹, D. Musgrove¹, D. Zaun¹, A. Wey¹, N. Salkowski¹, J. Rosendale², A. Israni¹, R. Hirose³, B. Kasiske¹

3:27pm-3:39pm

Clinical Outcomes from a Mobile Health, Pharmacist-Led Intervention: 12-Month Results of the Transafe Rx Randomized Controlled Trial

D. Taber, J. Hirsch, Z. Su, J. McGillicuddy, A. Posadas, J. Fleming

3:39pm-3:51pm

Highly Effective Short Course Therapy to Prevent Infection after Transplantation from HCV-Infected Organ Donors to Uninfected Recipients across Multiple Organ Types

A. Humar¹, M. Cypel¹, D. Kumar¹, H. Dahari², R. Vanin Pinto Ribeiro¹, N. Marks¹, N. Kamkar¹, I. Bahinskaya¹, F. Onofrio³, M. A. Zahoor³, O. Cerrochi³, K. Tinckam¹, S. J. Kim¹, T. W. Reichman¹, M. McDonald¹, T. K. Waddell¹, G. Sapisochin¹, M. Selzner¹, S. Keshavjee¹, H. L. Janssen³, B. E. Hansen³, L. Singer¹, J. Feld³

3:51pm-4:03pm

Interim Experience in a Phase 3 Prospective, Randomized, Multi-Center, Open-Label, Controlled Trial of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-Matched, Living Donor Kidney Transplants

D. Kaufman¹, J. Piper², M. Stegall³, S. Akkina⁴, E. Marin⁵, A. Gaber⁶, Y. Qasi⁷, T. Srinivas⁸, D. Alonso⁹, A. Patel¹⁰, M. Laftavi¹¹, A. Shah¹², S. Collette¹³, E. Stites¹⁴, K. Chavin⁸, S. Crowley¹⁵

4:03pm-4:15pm

Impact of Extended- versus Immediate-Release Tacrolimus on One-Year Development of De Novo DSA and Chronic Immune Activation in Kidney Transplantation (ASTOUND Study)

A. Wiseman¹, D. Kaufman², A. Patel³, D. Wojciechowski⁴, A. Tambur⁵, J. Kim⁶, J. Schwartz⁶

4:15pm-4:27pm

End-Hypothermic Oxygenated Machine Perfusion after Static Cold Storage versus Static Cold Storage Alone in Kidneys from Extended Criteria Brain-Dead Donors: An International Randomized Controlled Trial

P. Husen¹, C. Boffa², I. Jochmans³, C. Krikke⁴, L. Davies², H. Hofker⁴, J. Pirenne³, R. Ploeg², A. Paul¹

4:27pm-4:39pm

Feasibility and Long Term Safety of T Regulatory Cell Therapy in Kidney Transplantation

P. N. Harden¹, D. Game², J. Van der Net¹, F. Issa³, W. Petchey¹, M. Brook¹, P. Friend¹, R. Hilton⁴, G. Lombardi⁵, K. Wood³